Efficacy and safety of adjuvant ovarian suppression with Buserelin-depo in premenopausal women with hormone-positive breast cancer
Breast cancer (BC) ranks first in the morbidity pattern among women in Russia. Adjuvant endocrinotherapy is an important step in the complex treatment of premenopausal patients with hormone-positive early breast cancer. The drug ovarian suppression with GnRH-agonists have supplanted surgical castrat...
Main Authors: | L. K. Ovchinnikova, A. D. Belko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-06-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/3057 |
Similar Items
-
EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER
by: S. V. MISHUGIN, et al.
Published: (2017-06-01) -
Weaned Sows with Small Ovarian Follicles Respond Poorly to the GnRH Agonist Buserelin
by: Tania P. Lopes, et al.
Published: (2020-10-01) -
HALF-DOSE DEPOT TRIPTORELIN COMPARABLE TO REDUCED DAILY BUSERELIN: A RANDOMIZED CLINICAL TRIAL
by: L. Safdarian, et al.
Published: (2007-12-01) -
HALF-DOSE DEPOT TRIPTORELIN COMPARABLE TO REDUCED DAILY BUSERELIN: A RANDOMIZED CLINICAL TRIAL
by: L. Safdarian, et al.
Published: (2007-09-01) -
Effects of Gonadotropin Releasing Hormone Agonist (Buserelin) on Development of Ovarian Follicles of Adult Rats
by: Tahmineh Peirouvi, et al.
Published: (2016-08-01)